Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population. [electronic resource] by
- Hall, Stephen
- Nash, Peter
- Rischmueller, Maureen
- Bossingham, David
- Bird, Paul
- Cook, Nicola
- Witcombe, David
- Soma, Koshika
- Kwok, Kenneth
- Thirunavukkarasu, Krishan
Publication details: Rheumatology and therapy Dec 2018
In:
Rheumatology and therapy vol. 5
Availability: No items available.
|
|
8.
|
|
|
9.
|
Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety. [electronic resource] by
- Bird, Paul
- Bensen, William
- El-Zorkany, Bassel
- Kaine, Jeffrey
- Manapat-Reyes, Bernadette Heizel
- Pascual-Ramos, Virginia
- Witcombe, David
- Soma, Koshika
- Zhang, Richard
- Thirunavukkarasu, Krishan
Producer: 20190826
In:
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 25
Availability: No items available.
|